desvenlafaxine succinate
desvenlafaxine succinate is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including desvenlafaxine, Pristiq Extended-Release. Available dosage forms: tablet, extended release, powder.
Drug Details
- Generic Name
- desvenlafaxine succinate
- Brand Names
- desvenlafaxine, Pristiq Extended-Release
- Application Number
- ANDA204003
- Sponsor
- DIRECT RX
- NDC Codes
- 8
- Dosage Forms
- TABLET, EXTENDED RELEASE, POWDER
- Routes
- ORAL
- Active Ingredients
- DESVENLAFAXINE SUCCINATE
Indications and Usage
1 INDICATIONS AND USAGE Desvenlafaxine extended-release tablet is indicated for the treatment of adults with major depressive disorder (MDD) [see CLINICAL STUDIES ( 14 )]. Desvenlafaxine extended-release tablet, is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).